141 related articles for article (PubMed ID: 29483142)
21. Pathological polyploidy and liver repair failure in RAD51-deficient mice.
Duncan AW
Hepatology; 2024 Mar; ():. PubMed ID: 38546299
[No Abstract] [Full Text] [Related]
22. BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapy.
Oing C; Tennstedt P; Simon R; Volquardsen J; Borgmann K; Bokemeyer C; Petersen C; Dikomey E; Rothkamm K; Mansour WY
Cancer Lett; 2018 Jun; 423():60-70. PubMed ID: 29526801
[TBL] [Abstract][Full Text] [Related]
23. CtBP1 transactivates RAD51 and confers cisplatin resistance to breast cancer cells.
Deng Y; Guo W; Xu N; Li F; Li J
Mol Carcinog; 2020 May; 59(5):512-519. PubMed ID: 32124501
[TBL] [Abstract][Full Text] [Related]
24. DNA Repair Protein Rad51 Induces Tumor Growth and Metastasis in Esophageal Squamous Cell Carcinoma via a p38/Akt-Dependent Pathway.
Chiu WC; Fang PT; Lee YC; Wang YY; Su YH; Hu SC; Chen YK; Tsui YT; Kao YH; Huang MY; Yuan SF
Ann Surg Oncol; 2020 Jun; 27(6):2090-2101. PubMed ID: 31749080
[TBL] [Abstract][Full Text] [Related]
25. Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51.
Lee JO; Kang MJ; Byun WS; Kim SA; Seo IH; Han JA; Moon JW; Kim JH; Kim SJ; Lee EJ; In Park S; Park SH; Kim HS
Breast Cancer Res; 2019 Oct; 21(1):115. PubMed ID: 31640742
[TBL] [Abstract][Full Text] [Related]
26. Role of Rad51 and DNA repair in cancer: A molecular perspective.
Laurini E; Marson D; Fermeglia A; Aulic S; Fermeglia M; Pricl S
Pharmacol Ther; 2020 Apr; 208():107492. PubMed ID: 32001312
[TBL] [Abstract][Full Text] [Related]
27. Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo.
Maranto C; Udhane V; Jia J; Verma R; Müller-Newen G; LaViolette PS; Pereckas M; Sabharwal L; Terhune S; Pattabiraman N; Njar VCO; Imig JD; Wang L; Nevalainen MT
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33217941
[TBL] [Abstract][Full Text] [Related]
28. STAT5A reprograms fatty acid metabolism and promotes tumorigenesis of gastric cancer cells.
Dong SR; Ju XL; Yang WZ
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8360-8370. PubMed ID: 31646566
[TBL] [Abstract][Full Text] [Related]
29. Stat5 induces androgen receptor (
Maranto C; Sabharwal L; Udhane V; Pitzen SP; McCluskey B; Qi S; O'Connor C; Devi S; Johnson S; Jacobsohn K; Banerjee A; Iczkowski KA; Wang L; Dehm SM; Nevalainen MT
Sci Adv; 2024 Mar; 10(9):eadi2742. PubMed ID: 38416822
[TBL] [Abstract][Full Text] [Related]
30. In-depth analysis of the expression and functions of signal transducers and activators of transcription in human ovarian cancer.
Gong X; Liu X
Front Oncol; 2022; 12():1054647. PubMed ID: 36524006
[TBL] [Abstract][Full Text] [Related]
31. Targeting the STAT5A/IDO1 axis overcomes radioresistance and reverses the immunosuppressive tumor microenvironment in NSCLC.
Yang Y; Zheng X; Ni P; Li D; Dan Q; Wang X; Wang Y; Sun Y; Liu K; Dong Z; Ge H
Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36453241
[TBL] [Abstract][Full Text] [Related]
32. Association between Incidental Pelvic Inflammation and Aggressive Prostate Cancer.
Chakravarty D; Ratnani P; Huang L; Dovey Z; Sobotka S; Berryhill R; Merisaari H; Al Shaarani M; Rai R; Jambor I; Yadav KK; Mittan S; Parekh S; Kodysh J; Wagaskar V; Brody R; Cordon-Cardo C; Rykunov D; Reva B; Davicioni E; Wiklund P; Bhardwaj N; Nair SS; Tewari AK
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681714
[TBL] [Abstract][Full Text] [Related]
33. The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521.
Hall WA; Karrison TG; Rosenthal SA; Amin MB; Gomella LG; Purdy JA; Sartor AO; Michalski JM; Garzotto MG; Bergom C; Jani AB; Lawton CAF; Simko JP; Moore JK; Gore EM; Lee WR; Nguyen PL; Danielson BL; Sandler HM; Feng FY
Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):266-274. PubMed ID: 35675855
[TBL] [Abstract][Full Text] [Related]
34. SPP1 promotes radiation resistance through JAK2/STAT3 pathway in esophageal carcinoma.
Wang M; Sun X; Xin H; Wen Z; Cheng Y
Cancer Med; 2022 Dec; 11(23):4526-4543. PubMed ID: 35593388
[TBL] [Abstract][Full Text] [Related]
35. miR-1247-3p targets STAT5A to inhibit lung adenocarcinoma cell migration and chemotherapy resistance.
Lin J; Zheng X; Tian X; Guan J; Shi H
J Cancer; 2022; 13(7):2040-2049. PubMed ID: 35517418
[No Abstract] [Full Text] [Related]
36. Bridging Radiotherapy to Immunotherapy: The IFN-JAK-STAT Axis.
Shi LZ; Bonner JA
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830176
[TBL] [Abstract][Full Text] [Related]
37. Construction and validation of a novel aging-related gene signature and prognostic nomogram for predicting the overall survival in ovarian cancer.
Liu L; Zhao J; Du X; Zhao Y; Zou C; Zhou H; Li W; Yan X
Cancer Med; 2021 Dec; 10(24):9097-9114. PubMed ID: 34825509
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of HMGA1 confers radioresistance by transactivating RAD51 in cholangiocarcinoma.
Song J; Cui D; Wang J; Qin J; Wang S; Wang Z; Zhai X; Ma H; Ma D; Liu Y; Jin B; Liu Z
Cell Death Discov; 2021 Oct; 7(1):322. PubMed ID: 34716319
[TBL] [Abstract][Full Text] [Related]
39. Histone Deacetylase Inhibitor Trichostatin A Reduces Endothelial Cell Proliferation by Suppressing STAT5A-Related Gene Transcription.
Li Y; Zhao Y; Peng H; Zhang J; Bo L; Wen L; Liu W; Bai W; Zhang H
Front Oncol; 2021; 11():746266. PubMed ID: 34650929
[TBL] [Abstract][Full Text] [Related]
40. Impact of STAT Proteins in Tumor Progress and Therapy Resistance in Advanced and Metastasized Prostate Cancer.
Ebersbach C; Beier AK; Thomas C; Erb HHH
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
